Purine derivatives as cd73 inhibitors for the treatment of cancer

MA39986AUndetermined Publication Date: 2017-03-01VITAE PHARMA INC

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: MA39986
Authority / Receiving Office: MA · MA
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2014-09-17
Filing Date: 2015-04-23
Publication Date: 2017-03-01

Application Information

Patent Timeline

17 Sep 2014

Priority

23 Apr 2015

Application

MA39986

01 Mar 2017

Publication

MA39986A

IPC: A61K31/506; A61K31/675; A61K31/7052; A61P33/00; C07D405/04; C07D473/34; C07D473/36; C07D473/40; C07H19/06; C07H19/16

CPC: A61P33/00; A61P35/00; A61P35/02; A61P43/00; C07D239/72; C07D405/04; C07D473/34; C07D473/36

Inventors: CACATIAN Salvacion; CLAREMON David A.

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

Provided are novel compounds, pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are inhibitors of cd73 and are useful in the treatment of cancer.

Need to check novelty before this filing date? Find Prior Art